Urinary Incontinence: all 1,375 studies

Page 14 of 14. Open to participants first (224), then studies with results posted, then the rest; newest registration first within each.

• Retropubic vs. Transobturator Tension-free Vaginal TapeCompletedNCT00441454Not applicable
• ELB245 for 12 Weeks Versus 4mg Tolterodine in Patients With Incontinent Overactive Bladder (OAB)TerminatedNCT00439192Phase 2
• Safety and Applicability Study of a Novel Heat Flow Sensor Unit for Measuring Urinary Bladder CapacityStatus unknownNCT00437528
• Treatment of Enuresis Nocturna by Circular Muscle Exercise (Paula Method)Status unknownNCT00404638Not applicable
• Lumbar to Sacral Ventral Nerve Re-RoutingCompletedNCT00378664Phase 2
• Evaluate Women After Vaginal Surgery for Urinary Symptoms and Sexual FunctionCompletedNCT00376441
• Refractory Urge Incontinence and Botox InjectionsTerminatedNCT00373789Phase 3
• Comparison of Body and Room Temperature Saline in UrodynamicsStatus unknownNCT00355433Phase 4
• A Study of Solifenacin With Bladder Training Versus Solifenacin Alone in Patients With Overactive Bladder (SOLAR)CompletedNCT00337558Phase 4
• A Study to Evaluate Solifenacin Succinate in Combination With Tamsulosin for the Treatment of Residual Overactive Bladder Symptoms (OAB) in Men.CompletedNCT00333112Phase 4
• Effectiveness and Safety of Bulkamid® as Bulking Agent for the Treatment of Female Urinary IncontinenceCompletedNCT00333073Not applicable
• Effects Of GW679769 On Bladder Nerve Function And Symptoms Of Overactive Bladder In Spinal Cord Injury PatientsTerminatedNCT00332319Phase 2
• Laparoscopic Adjustable Gastric Banding With Truncal VagotomyTerminatedNCT00329862Not applicable
• Regaining Bladder Control in Postmenopausal Women With OsteoporosisCompletedNCT00323245Not applicable
• A Study Of GW679769 Compared To Placebo In Women With Overactive BladderCompletedNCT00321477Phase 2
• Efficacy and Safety of OROS Oybutynin and TTS Oxybutynin in Middle-Aged and Elderly Women With Urinary IncontinenceCompletedNCT00304499Phase 3
• Efficacy and Tolerability of DITROPAN XL (Oxybutynin Chloride) Versus DETROL LA (Tolterodine Tartrate) in Treatment of Overactive BladderCompletedNCT00293839Phase 3
• Safety and Efficacy of MK0594 to Treat Overactive Bladder (0594-003)CompletedNCT00290563Phase 2
• Surface Nerve Stimulation Treatment for OAB in ChildrenCompletedNCT00282490Not applicable
• Colpocleisis for Advanced Pelvic Organ ProlapseCompletedNCT00271037
• Treatment for Female Stress Urinary IncontinenceCompletedNCT00270738Not applicable
• Family Help Program: Nighttime Enuresis Treatment ProgramCompletedNCT00270621Phase 2
• A Study Comparing the Efficacy and Safety of OROS® Oxybutynin to That of Ditropan® (Immediate-release Oxybutynin) for the Treatment of Patients With Urge or Mixed Urinary Incontinence.CompletedNCT00269750Phase 3
• A Study to Evaluate the Safety and Efficacy of OROS® Oxybutynin Chloride for the Treatment of Urge Urinary IncontinenceCompletedNCT00269724Phase 3
• Botulinum-A Toxin Injection for Detrusor Hyperreflexia in Spinal Cord Injury: A Non-Surgical Approach.WithdrawnNCT00262496Phase 2
• Effect of Pelvic Floor Muscle Training in StrokeTerminatedNCT00258037Phase 2
• Analysis of Expression of Nitric Oxide Syntheses and Their Functional Role in Human UrotheliumTerminatedNCT00253006
• Weighted Vaginal Cones Versus Biofeedback in the Treatment of Urodynamic Stress Incontinence: a Randomized Trial.TerminatedNCT00247286Phase 4
• A Study of Oral Desmopressin in Previously Untreated Children Aged 5 to 15 Years With Primary Nocturnal EnuresisCompletedNCT00245479Phase 4
• To Determine How Effective Duloxetine is in Treating Women 65 Years and Older With Symptoms of Stress Urinary Incontinence, or With a Combination of Stress Urinary Incontinence and Urge Urinary Incontinence SymptomsCompletedNCT00244296Phase 4
• A Study to Determine if Ibuprofen in Combination With Pseudoephedrine HCl is More Effective Than Each Drug Alone in the Treatment of Nighttime BedwettingCompletedNCT00240812Phase 2
• Pelvic Floor Muscle Training to Treat Urinary Incontinence After Radical ProstatectomyCompletedNCT00239824Not applicable
• Programmable Timer in the Bladder Rehabilitation Treatment of OABCompletedNCT00238680Not applicable
• Trans-Obturator Tape Versus Trans-Vaginal Tape for Stress Urinary Incontinence in WomenCompletedNCT00234754Not applicable
• A Placebo-Controlled Study of MK0634 in Patients With Overactive Bladder (0634-007)CompletedNCT00231790Phase 2
• Effect Of Detrol LA With Behavioral Intervention In Overactive Bladder Subjects Dissatisfied With Recent OAB Medication.CompletedNCT00230789Phase 4
• Desmopressin Response in the YoungCompletedNCT00230594Phase 3
• The Effect of Indomethacin in Monosymptomatic Enuresis NocturnalCompletedNCT00226122Phase 4
• Transdermal (TDS) Oxybutynin (Oxytrol(r)) in Overactive BladderCompletedNCT00224146Phase 4
• Treatment for Stress and Mixed Urinary Incontinence and Vaginal Vault ProlapseCompletedNCT00223106Not applicable
• Pelvic Floor Muscle Training for Incontinence in Older Women.CompletedNCT00222248Not applicable
• A 6-week Open Label Cross-over Study With 2 Different Daily Doses of Minirin® Oral Lyophilisate in Children and Adolescents With Primary Nocturnal Enuresis (PNE)CompletedNCT00209261Phase 4
• A Clinical Evaluation of the Tension-Free Vaginal Tape Obturator System For Treatment of Stress Urinary Incontinence (Urinary Leakage)CompletedNCT00196521Not applicable
• Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive BladderCompletedNCT00196404Phase 2
• Open Label Phase III Duloxetine Study for Stress Urinary IncontinenceCompletedNCT00191204Phase 3
• Duloxetine in the Treatment of Stress Urinary Incontinence.CompletedNCT00191087Phase 3
• Evaluate Safety and Efficacy of Duloxetine in Predominant Stress Urinary IncontinenceCompletedNCT00190996Phase 3
• Safety and Effectiveness Study of Duloxetine HCl in Women of Different Backgrounds With Stress Urinary Incontinence Who May Also Have Other Various Medical Conditions.CompletedNCT00190905Phase 4
• Effectiveness of Duloxetine in the Treatment of Stress Urinary Incontinence(Uncontrolled Leakage of Urine)CompletedNCT00190827Phase 3
• Effectiveness and Safety of Duloxetine in Women Experiencing Urinary Leakage Due to Physical Stress and Urge.CompletedNCT00190814Phase 3
• To Evaluate the Safety of Duloxetine in Patients With Stress Urinary IncontinenceCompletedNCT00190645Phase 3
• To Evaluate the Safety in Patients Taking Duloxetine for Stress Urinary IncontinenceCompletedNCT00190632Phase 3
• Efficacy and Safety of Duloxetine, Placebo and Pelvic Floor Muscle Training in Subjects With Stress Urinary IncontinenceCompletedNCT00190606Phase 2
• Screening for Urinary Incontinence by Primary Care ProvidersCompletedNCT00178334
• Low-Intensity Physical Therapy for Prevention of Pre and Postpartum Urinary IncontinenceTerminatedNCT00178282Not applicable
• Further Enhancing Non-pharmacologic Therapy for IncontinenceCompletedNCT00177541Not applicable
• MILADY: A Randomized, Placebo-controlled Safety and Efficacy Trial of SSR240600C in Treatment of Overactive Bladder or Urge Urinary Incontinence.CompletedNCT00174798Phase 2
• Prevalence and Treatment of Urinary Incontinence in Women With Cystic Fibrosis and Chronic Obstructive Pulmonary DiseaseCompletedNCT00164138Not applicable
• Effect and Safety Of Detrol LA In Men With Overactive Bladder Symptoms With Or Without Bladder Outlet ObstructionCompletedNCT00147654Phase 4
• Effect of Detrol LA on Overactive Bladder Symptoms, Sexual Quality of Life and Sexual Function in WomenCompletedNCT00143481Phase 4
• Study to Determine The Effectiveness Of Detrusitol In Patients Diagnosed With OABCompletedNCT00143377Phase 4
• Evaluation Of A Novel Methodology In The Assessment Of Urethral Function Using SS-RBX.CompletedNCT00141128Phase 2
• Evaluate Efficacy and Safety Of Tolterodine Extended Release Capsule Compared With Tolterodine Immediate Release TabletCompletedNCT00139724Phase 3
• An 8 Week Study Looking At The Efficacy, Toleration And Safety Of SS-RBX For Stress Urinary Incontinence.CompletedNCT00138749Phase 2
• A Study to Measure the Effect of Tolterodine Extended Release on the Thickness of the Bladder Wall in Patients With Overactive BladderCompletedNCT00137397Phase 4
• Transvaginal Tension Free Vaginal Tape-Obturator (TVT-O) Versus Transobturator Tape-Mentor (TOT) in the Management of Urodynamic Stress Urinary IncontinenceStatus unknownNCT00136071Not applicable
• Treatment of Female Stress Urinary Incontinence: Study Comparing Two Suburethral Slings, Retropubic Approach (TVT) and Trans-Obturator (TVT-O) ApproachStatus unknownNCT00135616Phase 4
• Using Behavioral Therapy in Combination With Darifenacin for Symptoms of Overactive BladderCompletedNCT00127270Phase 4
• IRIS: Incontinence Research Intervention StudyCompletedNCT00125177Phase 1/2
• Treatment of Persistent Urinary Incontinence in ChildrenCompletedNCT00124046Not applicable
• Program to Reduce Incontinence by Diet and ExerciseCompletedNCT00091988Not applicable
• Use of Complementary and Alternative Medicine Among Older Mexican AmericansTerminatedNCT00084110
• Prevent Inability To Control UrinationCompletedNCT00075114Phase 3
• ORWH:SCOR on Sex and Gender Factors Affecting Women's IncontinenceCompletedNCT00069368
• Colpopexy and Urinary Reduction Efforts (CARE) ProtocolCompletedNCT00065845Phase 3

← Urinary Incontinence overview